| abstract |
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and pharmaceutically acceptable esters thereof:n n n Formula In n n n n n n n Wheren n n U, A 1 , A 2 , A 3 , A 4 , V, X, Y, Z, Q, m and n are as defined in the specification and claims.n n n The compound treats 2,3-oxidosqualene-lanosterol cyclase, such as hypercholesterolemia, hyperlipidemia, atherosclerosis, vascular disease, fungi, gallstones, dose and / or disorders associated with hyperproliferative disorders Or preventing and impairing glucose tolerance and / or preventing diabetes. |